IKT Inhibikase Therapeutics | $1.52 -0.7% | 11/12/2026 | | Reiterated Rating | $1.50 | Neutral | 00.00% | View details for Chardan Capital rating of Inhibikase Therapeutics (NASDAQ:IKT) on 11/12/2026 |
QMLS QumulusAI | $2.75 -2.1% | 11/11/2026 | | Lower Price Target | $13.00 | Buy | 00.00% | View details for Chardan Capital rating of QumulusAI (NASDAQ:QMLS) on 11/11/2026 |
HIVE HIVE Digital Technologies | $1.57 -4.8% | 11/10/2026 | | Lower Price Target | $7.50 ➝ $7.00 | Buy | 00.00% | View details for Chardan Capital rating of HIVE Digital Technologies (NASDAQ:HIVE) on 11/10/2026 |
MLTX MoonLake Immunotherapeutics | $12.50 -2.9% | 11/6/2026 | | Initiated Coverage | $57.00 | Buy | 00.00% | View details for Chardan Capital rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 11/6/2026 |
RIOT Riot Platforms | $17.52 -1.7% | 11/5/2026 | | Boost Price Target | $27.50 ➝ $32.00 | Buy | 00.00% | View details for Chardan Capital rating of Riot Platforms (NASDAQ:RIOT) on 11/5/2026 |
ALNY Alnylam Pharmaceuticals | $165.04 +5.4% | 10/30/2026 | | Lower Price Target | $425.00 ➝ $375.00 | Buy | 00.00% | View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 10/30/2026 |
KDK Kodiak AI | $1.11 -8.3% | 10/29/2026 | | Reiterated Rating | $4.50 | Buy | 00.00% | View details for Chardan Capital rating of Kodiak AI (NASDAQ:KDK) on 10/29/2026 |
ADAG Adagene | $1.71 -14.5% | 10/28/2026 | | Reiterated Rating | $9.00 | Buy | 00.00% | View details for Chardan Capital rating of Adagene (NASDAQ:ADAG) on 10/28/2026 |
PVLA Palvella Therapeutics | $152.48 -0.5% | 10/28/2026 | | Reiterated Rating | $240.00 | Buy | 00.00% | View details for Chardan Capital rating of Palvella Therapeutics (NASDAQ:PVLA) on 10/28/2026 |
GLXY Galaxy Digital | $14.38 -5.3% | 10/27/2026 | | Reiterated Rating | $35.00 | Buy | 00.00% | View details for Chardan Capital rating of Galaxy Digital (NASDAQ:GLXY) on 10/27/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
GOSS Gossamer Bio | $10.97 -2.4% | 10/26/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Chardan Capital rating of Gossamer Bio (NASDAQ:GOSS) on 10/26/2026 |
OBIO Orchestra BioMed | $7.25 +17.9% | 10/23/2026 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 10/23/2026 |
AGEN Agenus | $6.73 -2.0% | 10/22/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Chardan Capital rating of Agenus (NASDAQ:AGEN) on 10/22/2026 |
IRD Opus Genetics | $3.98 -2.0% | 10/22/2026 | | Reiterated Rating | $16.00 | Buy | 00.00% | View details for Chardan Capital rating of Opus Genetics (NASDAQ:IRD) on 10/22/2026 |
KDK Kodiak AI | $1.11 -8.3% | 10/22/2026 | | Lower Price Target | $4.50 | Buy | 00.00% | View details for Chardan Capital rating of Kodiak AI (NASDAQ:KDK) on 10/22/2026 |
RANI Rani Therapeutics | $0.53 +0.2% | 10/22/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Chardan Capital rating of Rani Therapeutics (NASDAQ:RANI) on 10/22/2026 |
SLN Silence Therapeutics | $19.83 +0.2% | 10/21/2026 | | Downgrade | | Strong-Buy ➝ Hold | 00.00% | View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 10/21/2026 |
TVRD Tvardi Therapeutics | $1.18 +2.2% | 10/20/2026 | | Initiated Coverage | | Buy | 00.00% | View details for Chardan Capital rating of Tvardi Therapeutics (NASDAQ:TVRD) on 10/20/2026 |
MNKD MannKind | $4.13 -0.7% | 10/19/2026 | | Initiated Coverage | $10.00 | Buy | 00.00% | View details for Chardan Capital rating of MannKind (NASDAQ:MNKD) on 10/19/2026 |
VFS VinFast Auto | $3.05 -0.3% | 10/16/2026 | | Reiterated Rating | $5.50 | Buy | 00.00% | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 10/16/2026 |
ARWR Arrowhead Pharmaceuticals | $47.78 +1.3% | 10/15/2026 | | Reiterated Rating | $115.00 | Buy | 00.00% | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 10/15/2026 |
IKT Inhibikase Therapeutics | $1.52 -0.7% | 10/13/2026 | | Set Price Target | $1.50 | Neutral | 00.00% | View details for Chardan Capital rating of Inhibikase Therapeutics (NASDAQ:IKT) on 10/13/2026 |
GOSS Gossamer Bio | $10.97 -2.4% | 10/13/2026 | | Initiated Coverage | | Buy | 00.00% | View details for Chardan Capital rating of Gossamer Bio (NASDAQ:GOSS) on 10/13/2026 |
IKT Inhibikase Therapeutics | $1.52 -0.7% | 10/13/2026 | | Initiated Coverage | $1.50 | Hold | 00.00% | View details for Chardan Capital rating of Inhibikase Therapeutics (NASDAQ:IKT) on 10/13/2026 |
ZPTA Zapata Quantum | $0.60 -9.8% | 10/13/2026 | | Initiated Coverage | $1.00 | Buy | 00.00% | View details for Chardan Capital rating of Zapata Quantum (OTCMKTS:ZPTA) on 10/13/2026 |
DUOT Duos Technologies Group | $5.03 -1.6% | 10/9/2026 | | Initiated Coverage | $9.50 | Neutral | 00.00% | View details for Chardan Capital rating of Duos Technologies Group (NASDAQ:DUOT) on 10/9/2026 |
RCKT Rocket Pharmaceuticals | $2.30 -3.8% | 10/7/2026 | | Reiterated Rating | $11.00 | Buy | 00.00% | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 10/7/2026 |
FDMT 4D Molecular Therapeutics | $12.23 +1.0% | 10/6/2026 | | Lower Price Target | $26.00 ➝ $25.00 | Buy | 00.00% | View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 10/6/2026 |
AGEN Agenus | $6.73 -2.0% | 10/5/2026 | | Reiterated Rating | $40.00 | Buy | 00.00% | View details for Chardan Capital rating of Agenus (NASDAQ:AGEN) on 10/5/2026 |
IRD Opus Genetics | $3.98 -2.0% | 10/2/2026 | | Reiterated Rating | $16.00 | Buy | 00.00% | View details for Chardan Capital rating of Opus Genetics (NASDAQ:IRD) on 10/2/2026 |
OCUL Ocular Therapeutix | $6.21 -1.1% | 10/2/2026 | | Reiterated Rating | $23.00 | Buy | 00.00% | View details for Chardan Capital rating of Ocular Therapeutix (NASDAQ:OCUL) on 10/2/2026 |
PRQR ProQR Therapeutics | $1.41 +3.7% | 10/1/2026 | | Reiterated Rating | $3.00 | Buy | 00.00% | View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 10/1/2026 |
DYN Dyne Therapeutics | $17.16 +0.9% | 9/30/2026 | | Reiterated Rating | $38.00 | Buy | 00.00% | View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 9/30/2026 |
QMLS QumulusAI | $2.75 -2.1% | 9/30/2026 | | Reiterated Rating | $23.00 | Buy | 00.00% | View details for Chardan Capital rating of QumulusAI (NASDAQ:QMLS) on 9/30/2026 |
CAMP CAMP4 Therapeutics | $3.80 -7.1% | 9/29/2026 | | Lower Price Target | $6.50 ➝ $6.00 | Buy | 00.00% | View details for Chardan Capital rating of CAMP4 Therapeutics (NASDAQ:CAMP) on 9/29/2026 |
KDK Kodiak AI | $1.11 -8.3% | 9/25/2026 | | Reiterated Rating | $12.00 | Buy | 00.00% | View details for Chardan Capital rating of Kodiak AI (NASDAQ:KDK) on 9/25/2026 |
PRME Prime Medicine | $4.27 +9.8% | 9/25/2026 | | Reiterated Rating | $7.00 | Buy | 00.00% | View details for Chardan Capital rating of Prime Medicine (NASDAQ:PRME) on 9/25/2026 |
PVLA Palvella Therapeutics | $152.48 -0.5% | 9/21/2026 | | Initiated Coverage | $240.00 | Buy | 00.00% | View details for Chardan Capital rating of Palvella Therapeutics (NASDAQ:PVLA) on 9/21/2026 |
AGEN Agenus | $6.73 -2.0% | 9/18/2026 | | Initiated Coverage | $40.00 | Buy | 00.00% | View details for Chardan Capital rating of Agenus (NASDAQ:AGEN) on 9/18/2026 |
MOVE Corvex | $4.47 -5.1% | 9/16/2026 | | Set Price Target | $18.75 | Buy | 00.00% | View details for Chardan Capital rating of Corvex (NASDAQ:MOVE) on 9/16/2026 |
This is likely to EXPLODE (Ad) Dr. Martin D. Weiss, founder of Weiss Ratings and a two-time Congressional witness on financial institution risk, is warning of a looming $3 trillion threat in today's financial system.
He says the same ratings agency practices that preceded the 2008 crisis are repeating themselves, while regulators stay quiet about the risks. Watch Dr Weiss's free video to learn how to protect your money |
HIVE HIVE Digital Technologies | $1.57 -4.8% | 9/16/2026 | | Reiterated Rating | $7.50 | Buy | 00.00% | View details for Chardan Capital rating of HIVE Digital Technologies (NASDAQ:HIVE) on 9/16/2026 |
MOVE Corvex | $4.47 -5.1% | 9/16/2026 | | Initiated Coverage | $18.75 | Buy | 00.00% | View details for Chardan Capital rating of Corvex (NASDAQ:MOVE) on 9/16/2026 |
OCUL Ocular Therapeutix | $6.21 -1.1% | 9/16/2026 | | Reiterated Rating | $23.00 | Buy | 00.00% | View details for Chardan Capital rating of Ocular Therapeutix (NASDAQ:OCUL) on 9/16/2026 |
RCKT Rocket Pharmaceuticals | $2.30 -3.8% | 9/15/2026 | | Reiterated Rating | $11.00 | Buy | 00.00% | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 9/15/2026 |
ADAG Adagene | $1.71 -14.5% | 9/10/2026 | | Initiated Coverage | $9.00 | Buy | 00.00% | View details for Chardan Capital rating of Adagene (NASDAQ:ADAG) on 9/10/2026 |
IRD Opus Genetics | $3.98 -2.0% | 9/9/2026 | | Boost Price Target | $13.00 ➝ $16.00 | Buy | 00.00% | View details for Chardan Capital rating of Opus Genetics (NASDAQ:IRD) on 9/9/2026 |
IRD Opus Genetics | $3.98 -2.0% | 9/9/2026 | | Reiterated Rating | $13.00 | Buy | 00.00% | View details for Chardan Capital rating of Opus Genetics (NASDAQ:IRD) on 9/9/2026 |
KDK Kodiak AI | $1.11 -8.3% | 9/9/2026 | | Reiterated Rating | $12.00 | Buy | 00.00% | View details for Chardan Capital rating of Kodiak AI (NASDAQ:KDK) on 9/9/2026 |
HYPD Hyperion DeFi | $2.58 -5.1% | 9/8/2026 | | Boost Price Target | $7.30 ➝ $8.45 | Buy | 00.00% | View details for Chardan Capital rating of Hyperion DeFi (NASDAQ:HYPD) on 9/8/2026 |
HIND Vyome | $1.58 -3.1% | 9/3/2026 | | Initiated Coverage | $3.50 | Buy | 00.00% | View details for Chardan Capital rating of Vyome (NASDAQ:HIND) on 9/3/2026 |
HIND Vyome | $1.58 -3.1% | 9/3/2026 | | Initiated Coverage | $3.50 | Buy | 00.00% | View details for Chardan Capital rating of Vyome (NASDAQ:HIND) on 9/3/2026 |
RCKT Rocket Pharmaceuticals | $2.30 -3.8% | 9/1/2026 | | Initiated Coverage | $11.00 | Buy | 00.00% | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 9/1/2026 |
ARWR Arrowhead Pharmaceuticals | $47.78 +1.3% | 8/31/2026 | | Reiterated Rating | $115.00 | Buy | 00.00% | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 8/31/2026 |
PURR Hyperliquid Strategies | $8.70 -1.2% | 8/28/2026 | | Boost Price Target | $9.75 ➝ $17.00 | Buy | 00.00% | View details for Chardan Capital rating of Hyperliquid Strategies (NASDAQ:PURR) on 8/28/2026 |
PURR Hyperliquid Strategies | $8.70 -1.2% | 8/27/2026 | | Reiterated Rating | $9.75 | Buy | 00.00% | View details for Chardan Capital rating of Hyperliquid Strategies (NASDAQ:PURR) on 8/27/2026 |
ODYS Odysight.ai | $1.78 +8.5% | 8/26/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of Odysight.ai (NASDAQ:ODYS) on 8/26/2026 |
QMLS QumulusAI | $2.75 -2.1% | 8/26/2026 | | Reiterated Rating | $24.50 | Buy | 00.00% | View details for Chardan Capital rating of QumulusAI (NASDAQ:QMLS) on 8/26/2026 |
RANI Rani Therapeutics | $0.53 +0.2% | 8/26/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of Rani Therapeutics (NASDAQ:RANI) on 8/26/2026 |
ZOOZ ZOOZ Power | $5.40 -4.3% | 8/26/2026 | | Reiterated Rating | $10.00 | Buy | 00.00% | View details for Chardan Capital rating of ZOOZ Power (NASDAQ:ZOOZ) on 8/26/2026 |
PRME Prime Medicine | $4.27 +9.8% | 8/25/2026 | | Initiated Coverage | $7.00 | Buy | 00.00% | View details for Chardan Capital rating of Prime Medicine (NASDAQ:PRME) on 8/25/2026 |
PRME Prime Medicine | $4.27 +9.8% | 8/25/2026 | | Initiated Coverage | $7.00 | Buy | 00.00% | View details for Chardan Capital rating of Prime Medicine (NASDAQ:PRME) on 8/25/2026 |
EYPT Eyepoint Pharmaceuticals | $0.31 -4.2% | 8/18/2026 | | Downgrade | $5.00 | Buy ➝ Neutral | 00.00% | View details for Chardan Capital rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 8/18/2026 |
RANI Rani Therapeutics | $0.53 +0.2% | 8/18/2026 | | Initiated Coverage | | Buy | 00.00% | View details for Chardan Capital rating of Rani Therapeutics (NASDAQ:RANI) on 8/18/2026 |
EYPT Eyepoint Pharmaceuticals | $0.31 -4.2% | 8/17/2026 | | Downgrade | $5.00 | Buy ➝ Neutral | 00.00% | View details for Chardan Capital rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 8/17/2026 |
HIVE HIVE Digital Technologies | $1.57 -4.8% | 8/17/2026 | | Reiterated Rating | $7.50 | Buy | 00.00% | View details for Chardan Capital rating of HIVE Digital Technologies (NASDAQ:HIVE) on 8/17/2026 |
ODYS Odysight.ai | $1.78 +8.5% | 8/17/2026 | | Initiated Coverage | $7.15 | Buy | 00.00% | View details for Chardan Capital rating of Odysight.ai (NASDAQ:ODYS) on 8/17/2026 |
COYA Coya Therapeutics | $3.13 -4.3% | 8/12/2026 | | Reiterated Rating | $14.00 | Buy | 00.00% | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 8/12/2026 |
QMLS QumulusAI | $2.75 -2.1% | 8/12/2026 | | Initiated Coverage | $24.50 | Buy | 00.00% | View details for Chardan Capital rating of QumulusAI (NASDAQ:QMLS) on 8/12/2026 |
VFS VinFast Auto | $3.05 -0.3% | 8/12/2026 | | Reiterated Rating | $5.50 | Buy | 00.00% | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 8/12/2026 |
HYPD Hyperion DeFi | $2.58 -5.1% | 8/11/2026 | | Reiterated Rating | $7.30 | Buy | 00.00% | View details for Chardan Capital rating of Hyperion DeFi (NASDAQ:HYPD) on 8/11/2026 |
TENX Tenax Therapeutics | $1.62 +0.6% | 8/11/2026 | | Downgrade | $5.00 | Buy ➝ Neutral | 00.00% | View details for Chardan Capital rating of Tenax Therapeutics (NASDAQ:TENX) on 8/11/2026 |
CLSK Cleanspark | $6.65 -2.8% | 8/10/2026 | | Reiterated Rating | $21.00 | Buy | 00.00% | View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 8/10/2026 |
EYPT Eyepoint Pharmaceuticals | $0.31 -4.2% | 8/7/2026 | | Reiterated Rating | $65.00 | Buy | 00.00% | View details for Chardan Capital rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 8/7/2026 |
GLXY Galaxy Digital | $14.38 -5.3% | 8/5/2026 | | Reiterated Rating | $35.00 | Buy | 00.00% | View details for Chardan Capital rating of Galaxy Digital (NASDAQ:GLXY) on 8/5/2026 |
WULF TeraWulf | $12.62 -3.2% | 8/5/2026 | | Reiterated Rating | $32.00 | Buy | 00.00% | View details for Chardan Capital rating of TeraWulf (NASDAQ:WULF) on 8/5/2026 |
CIFR Cipher Mining | $6.86 -4.1% | 8/4/2026 | | Reiterated Rating | $32.00 | Buy | 00.00% | View details for Chardan Capital rating of Cipher Mining (NASDAQ:CIFR) on 8/4/2026 |
OCUL Ocular Therapeutix | $6.21 -1.1% | 8/4/2026 | | Reiterated Rating | $23.00 | Buy | 00.00% | View details for Chardan Capital rating of Ocular Therapeutix (NASDAQ:OCUL) on 8/4/2026 |
STOK Stoke Therapeutics | $26.68 +1.8% | 8/4/2026 | | Reiterated Rating | $35.00 | Buy | 00.00% | View details for Chardan Capital rating of Stoke Therapeutics (NASDAQ:STOK) on 8/4/2026 |
CRVO CervoMed | $1.69 -7.7% | 8/3/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of CervoMed (NASDAQ:CRVO) on 8/3/2026 |
IMRX Immuneering | $3.71 +1.1% | 8/3/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 8/3/2026 |
KRYS Krystal Biotech | $305.23 -0.1% | 8/3/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 8/3/2026 |
ALNY Alnylam Pharmaceuticals | $165.04 +5.4% | 7/31/2026 | | Reiterated Rating | $425.00 | Buy | 00.00% | View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 7/31/2026 |
TENX Tenax Therapeutics | $1.62 +0.6% | 7/31/2026 | | Reiterated Rating | $27.00 | Buy | 00.00% | View details for Chardan Capital rating of Tenax Therapeutics (NASDAQ:TENX) on 7/31/2026 |
CLSK Cleanspark | $6.65 -2.8% | 7/28/2026 | | Boost Price Target | $19.00 ➝ $21.00 | Buy | 00.00% | View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 7/28/2026 |
FDMT 4D Molecular Therapeutics | $12.23 +1.0% | 7/28/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 7/28/2026 |
LXEO Lexeo Therapeutics | $2.87 -1.4% | 7/28/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 7/28/2026 |
PVLA Palvella Therapeutics | $152.48 -0.5% | 7/28/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of Palvella Therapeutics (NASDAQ:PVLA) on 7/28/2026 |
PMN Promis Neurosciences | $3.29 -5.5% | 7/27/2026 | | Set Price Target | $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Promis Neurosciences (NASDAQ:PMN) on 7/27/2026 |
HIVE HIVE Digital Technologies | $1.57 -4.8% | 7/27/2026 | | Initiated Coverage | $7.50 | Buy | 00.00% | View details for Chardan Capital rating of HIVE Digital Technologies (NASDAQ:HIVE) on 7/27/2026 |
CIFR Cipher Mining | $6.86 -4.1% | 7/27/2026 | | Initiated Coverage | $32.00 | Buy | 00.00% | View details for Chardan Capital rating of Cipher Mining (NASDAQ:CIFR) on 7/27/2026 |
Executive Order 14241 Unleashes Trump’s New Dollar (Ad) A landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December.
The agenda at the upcoming G20 Summit in Miami has shifted, and new research points to a major monetary announcement from President Trump.
A new documentary breaks down what this shift could mean for savings, investments, and the assets tied to it. Watch the documentary to see what the dollar reset means for you |
WULF TeraWulf | $12.62 -3.2% | 7/27/2026 | | Initiated Coverage | $32.00 | Buy | 00.00% | View details for Chardan Capital rating of TeraWulf (NASDAQ:WULF) on 7/27/2026 |
CIFR Cipher Mining | $6.86 -4.1% | 7/27/2026 | | Initiated Coverage | $32.00 | Buy | 00.00% | View details for Chardan Capital rating of Cipher Mining (NASDAQ:CIFR) on 7/27/2026 |
HIVE HIVE Digital Technologies | $1.57 -4.8% | 7/27/2026 | | Initiated Coverage | $7.50 | Buy | 00.00% | View details for Chardan Capital rating of HIVE Digital Technologies (NASDAQ:HIVE) on 7/27/2026 |
PMN Promis Neurosciences | $3.29 -5.5% | 7/27/2026 | | Initiated Coverage | $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Promis Neurosciences (NASDAQ:PMN) on 7/27/2026 |
WULF TeraWulf | $12.62 -3.2% | 7/27/2026 | | Initiated Coverage | $32.00 | Buy | 00.00% | View details for Chardan Capital rating of TeraWulf (NASDAQ:WULF) on 7/27/2026 |
ARWR Arrowhead Pharmaceuticals | $47.78 +1.3% | 7/22/2026 | | Boost Price Target | $90.00 ➝ $115.00 | Buy | 00.00% | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 7/22/2026 |
CLSK Cleanspark | $6.65 -2.8% | 7/15/2026 | | Reiterated Rating | $19.00 | Buy | 00.00% | View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 7/15/2026 |
CLSK Cleanspark | $6.65 -2.8% | 7/8/2026 | | Reiterated Rating | $19.00 | Buy | 00.00% | View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 7/8/2026 |
MGX Metagenomi | $0.69 -3.1% | 7/7/2026 | | Initiated Coverage | $7.00 ➝ $5.00 | Buy | 00.00% | View details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 7/7/2026 |
IRD Opus Genetics | $3.98 -2.0% | 7/6/2026 | | Reiterated Rating | $13.00 | Buy | 00.00% | View details for Chardan Capital rating of Opus Genetics (NASDAQ:IRD) on 7/6/2026 |